**3rd edition as of August 2022**

**#**

20th to 21st Centuries, and views of mental illness – Section 1.4.6

**A**

Abnormal behavior – Section 1.1.1

Abnormal psychology – Section 1.1.3

Absolute refractory period – Section 2.2.1.4

Acceptance techniques – Section 2.3.3.5

Action potential – Section 2.2.1.4

Acute Stress Disorder – Section 5.2.2

Epidemiology of – Section 5.3.2

Comorbidity of – Section 5.4.2

Adjustment Disorder – Section 5.2.3

Epidemiology of – Section 5.3.3

Comorbidity of – Section 5.4.3

Affective flattening – Section 12.1.1.6

Agoraphobia – Section 7.1.3

Comorbidity – Section 7.3.3

Epidemiology of – Section 7.2.3

Treatment of – Section 7.5.3

All-or-nothing principle Section 2.2.1.4

Alogia – Section 12.1.1.6

Alzheimer’s disease – Section 14.3.1

American Law Institute standard – Section 15.1.3

Amygdala – Section 2.2.1.6

Anal Stage – Section 2.3.1.2

Anhedonia – Section 12.1.1.6

Anorexia nervosa – Section 10.1.1

and EDNOS – Section 10.2.3

Comorbidity – Section 10.4.1

Treatment of – Section 10.6.1

Antecedents – Section 3.1.3.6

Antisocial personality disorder – Section 13.1.3.1

Treatment of – Section 13.5.2.1

Apathy – Section 12.1.1.6

Asociality – Section 12.1.1.6

Attributions and cognitive errors – Section 2.3.3.3

Avoidant personality disorder – Section 13.1.4.1

Avolition – Section 12.1.1.6

Axon – Section 2.2.1.3

Axon terminals – Section 2.2.1.3

**B**

Bandura, A. – Section 2.3.2.4

Behavioral assessment – Section 3.1.3.6

Behavioral model – Section 2.3.2

Evaluation of – Section 2.3.2.5

Related to mood disorders – Section 4.5.3

Related to anxiety disorders – Section 7.4.2.2

Related to somatic disorders – Section 8.4.3

Related to obsessive compulsive disorders – Section 9.4.3

Related to substance use and addictive disorders – Section 11.4.3; 11.5.2

Related to personality disorders – Section 13.4.2.3

Behavior modification – Section 2.3.2.5

Behaviors – Section 3.1.3.6

Binge eating disorder (BED) – Section 10.1.3

and EDNOS – Section 10.2.2

Comorbidity – Section 10.4.3

Treatment of – Section 10.6.3

Biological model – Section 2.2

Related to mood disorders – Section 4.5.1

Related to trauma and stressor related disorders – Section 5.5.1

Related to dissociative disorders – Section 6.4.1

Related to anxiety disorders – Section 7.4.1

Related to obsessive compulsive disorders – Section 9.4.1

Related to eating disorders – Section 10.5.1

Related to substance use and addictive disorders – Section 11.4.1; 11.5.1

Related to schizophrenic disorders – Section 12.4.1

Related to personality disorders – Section 13.4.1

Biological or somatogenic perspective – Section 1.4.6.1

Bipolar Disorder I and II – Section 4.2

Epidemiology of – Section 4.3.2

Comorbidity of – Section 4.4.2

Treatment of – Section 4.6.2

Bobo Doll experiment – Section 2.3.2.4

Body Dysmorphic Disorder – Section 9.1.2

Epidemiology of – Section 9.2.2

Comorbidity of – Section 9.3.2

Treatment of – Section 9.5.2

Borderline personality disorder – Section 13.1.3.2

Treatment of – Section 13.5.2.2

Brain structure and chemistry – Section 2.2.1

Bulimia nervosa – Section 10.1.2

and EDNOS – Section 10.2.4

Comorbidity – Section 10.4.2

Treatment of – Section 10.6.2

**C**

Cardiovascular – Section 8.6.1.4

Catatonic behavior – Section 12.1.1.5

Cathartic method – Section 1.4.6.2

Cerebellum – Section 2.2.1.6

Cerebrum, lobes – Section 2.2.1.6

Chronic traumatic encephalopathy (CTE) – Section 14.3.2

Civil commitment – Section 15.1.2

Classification – Section 1.2

Classification systems – Section 3.2.1

Client-centered therapy – Section 2.3.4.1

Client-therapist relationship – Section 3.3.1.4; Section 15.3

Clinical assessment – Section 3.1.1

Clinical description – Section 1.2

Clinical diagnosis – Section 3.2.1

Clinical interview – Section 3.1.3.2

Cognitive behavioral therapy – Section 2.3.3.5; Section 5.6.3

In relation to schizophrenic disorders – Section 12.5.2.1

Cognitive coping skills training – Section 2.3.3.5

Cognitive model – Section 2.3.3

Evaluation of – Section 2.3.3.6

Related to mood disorders – Section 4.5.2

Related to trauma and stressor related disorders – Section 5.5.1

Related to dissociative disorders – Section 6.4.2

Related to anxiety disorders – Section 7.4.2.1

Related to somatic disorders – Section 8.4.2

Related to obsessive compulsive disorders – Section 9.4.2

Related to eating disorders – Section 10.5.2

Related to substance use and addictive disorders – Section 11.4.2; 11.5.3

Related to schizophrenic disorders – Section 12.4.2.1

Related to personality disorders – Section 13.4.2.2

Cognitive restructuring – Section 2.3.3.5

Cognitive therapies – Section 2.3.3.5

Comorbidity – Section 1.2

Of mood disorders – Section 4.4

Of trauma and stressor related disorders – Section 5.4

Of dissociative disorders – Section 6.3

Of somatic disorders – Section 8.3

Of obsessive compulsive disorders – Section 9.3

Of eating disorders – Section 10.4

Of substance-related and addictive disorders – Section 11.3

Of schizophrenic disorders – Section 12.3

Of personality disorders – Section 13.3

Competent to stand trial – Section 15.1.3

Computed tomography (CT scan) – Section 3.1.3.4

Concussion – Section 14.3.2

Conditioning – Section 2.3.2.1

Confidentiality – Section 15.3

Consequences – Section 3.1.3.6

Contingencies – Section 2.3.2.3

Conversion disorder – Section 8.1.3

Counterconditioning – Section 2.3.2.2

Course – Section 1.2

Cost of mental illness – Section 1.1.2

Criminal commitment – Section 15.1.3

Cultural-sensitive therapies – Section 2.4.4

Culture – Section 1.1.2

Current views/trends, in mental illness – Section 1.4.7

**D**

Dangerousness – Section 1.1.2; 15.1.2.3

Deinstitutionalization – Section 1.4.7.2

Delirium – Section 14.1.1

Delusional disorder – Section 12.1.5

Delusions – Section 12.1.1.1

Dementia – Section 14.1.2

With Lewy bodies – Section 14.3.5

Dendrites – Section 2.2.1.3

Denial – Section 2.3.1.3

Dependent personality disorder – Section 13.1.4.2

Depersonalization/Derealization Disorder – Section 6.1.3

Treatment of – Section 6.5.3

Depolarized – Section 2.2.1.4

Depressants – Section 11.1.2.1

Epidemiology of – 11.2.1

Depressive disorders

Epidemiology of – Section 4.3.1

Comorbidity of – Section 4.4.1

Treatment of – Section 4.6.1

Deviance – Section 1.1.2

Diagnosis, elements of – Section 3.2.2.2

Disorganized thinking – Section 12.1.1.3

Displacement – Section 2.3.1.3

Dissociative disorders – Section 6.1

Dissociative amnesia disorder – Section 6.1.2

Treatment of – Section 6.5.2

Dissociative identity disorder – Section 6.1.1

Treatment of – Section 6.5.1

Distress – Section 1.1.2

Dopamine – Section 2.2.1.5

Dream Analysis – Section 2.3.1.4

DSM – Section 3.2.2

Disorder categories – Section 3.2.2.3

Durham test (products test) – Section 15.1.3

Duty to Warn – Section 15.3

Dysfunction – Section 1.1.2

**E**

Eating Disorder Not Otherwise Specified (EDNOS) – Section 10.2

Ego defense mechanisms – Section 2.3.1.3

Electroconvulsive therapy – Section 2.2.3.2

Enactive learning – Section 2.3.2.4

Environmental factors, and mental illness – Section 2.4.3

Endorphins – Section 2.2.1.5

Enzymatic degradation – Section 2.2.1.4

Epidemiological study – Section 1.5.2.4

Epidemiology – Section 1.2

Of mood disorders – Section 4.3

Of trauma and stressor related disorders – Section 5.3

Of dissociative disorders – Section 6.2

Of anxiety disorders – Section 5.2

Of somatic disorders – Section 8.2

Of obsessive-compulsive disorders – Section 9.2

Of eating disorders – Section 10.3

Of substance-related and addictive disorders – Section 11.2

Of schizophrenic disorders – Section 12.2

Of personality disorders – Section 13.2

Of neurocognitive disorders – Section 14.2

Eros – Section 2.3.1.1

Erotomanic delusion – Section 12.1.5

Etiology – Section 1.2

of mood disorders – Section 4.5

of trauma and stressor related disorders – Section 5.5

Of dissociative disorders – Section 6.4

Of anxiety disorders – Section 7.4

Of somatic disorders – Section 8.4

Of obsessive compulsive disorders – Section 9.4

Of eating disorders – Section 10.5

Of substance-related and addictive disorders – Section 11.4

Of schizophrenic disorders – Section 12.4

Of personality disorders – Section 13.4

Of neurocognitive disorders – Section 14.3

Existential perspective – Section 2.3.4.2

Evaluation of – Section 2.3.4.3

Exorcism – Section 1.4.1

Experiments – Section 1.5.2.5

Exposure therapy – Section 5.6.2

Extinction, operant conditioning – Section 2.3.2.3

Eye Movement Desensitization and Reprocessing (EMDR) – Section 5.6.4

**F**

Factitious disorder – Section 8.1.4

Family interventions

In relation to schizophrenic disorders – Section 12.5.3

Federal Insanity Defense Reform ACT (IDRA) – Section 15.1.3

Fire – Section 2.2.1.4

Fixated – Section 2.3.1.2

Flooding – Section 2.3.2.2

Forensic/legal psychology – Section 15.1.1

Free Association – Section 2.3.1.4

Frontotemporal NCD – Section 14.3.6

Fundamental attribution error – Section 2.3.3.3

**G**

GABA – Section 2.2.1.5

Gastrointestinal – Section 8.6.1.1

Gender factors, and mental illness – Section 2.4.2

Generalized Anxiety Disorder – Section 7.1.1

Comorbidity – Section 7.3.1

Epidemiology of – Section 7.2.1

Treatment of – Section 7.5.1

Genetic explanations for mental illness – Section 2.2.2.1

Genital Stage – Section 2.3.1.2

Glial Cells – Section 2.2.1.3

Glutamate – Section 2.2.1.5

Grandiose delusion – Section 12.1.5

Greco-Roman Thought – Section 1.4.2

Guilty but mentally ill (GBMI) – Section 15.1.3

**H**

Habituation – Section 2.3.2.1

Hallucinations – Section 12.1.1.1

Hallucinogens/Cannabis/Combination – Section 11.1.2.5

Epidemiology of – 11.2.3

Headaches – Section 8.6.1.1

Heuristics – Section 1.3

Hippocampus – Section 2.2.1.6

History, of mental illness – Section 1.4

Histrionic personality disorder – Section 13.1.3.3

Treatment of – Section 13.5.2.3

HIV Infection – Section 14.3.9

Hoarding – Section 9.1.3

Epidemiology of – Section 9.2.3

Comorbidity of – Section 9.3.3

Treatment of – Section 9.5.3

Hormonal imbalances – Section 2.2.2.2

Huntington’s disease – Section 14.3.8

Hypomanic Episode – Section 4.2

Humanistic perspective – Section 2.3.4.1

Evaluation of – Section 2.3.4.3

Hypertension – Section 8.6.1.1

Hypnosis – Section 8.6.2.3

Hypothalamus – Section 2.2.1.6

**I**

ICD – Section 3.2.3

Ideas of reference – Section 13.1.2.3

Identification – Section 2.3.1.3

Illness anxiety disorder – Section 8.1.2

Incidence – Section 1.2

Insomnia – Section 8.6.1.3

Intellectualization – Section 2.3.1.3

Intelligence tests – Section 3.1.3.7

Ions – Section 2.2.1.4

Irresistible impulse test – Section 15.1.3

**J**

Jealous delusion – Section 12.1.5

**K**

** **

**L**

Latency Stage – Section 2.3.1.2

Latent content, of dreams – Section 2.3.1.4

Law of effect – Section 2.3.2.3

Learning – Section 2.3.2.1

Levels of personality (conscious, preconscious, unconscious) – Section 2.3.1.1

Libido – Section 2.3.1.1

**M**

Magnetic Resonance Imaging (MRI) – Section 3.1.3.4

Major Depressive Disorder – Section 4.1

Major Depressive Episode – Section 4.1

Major Neurocognitive Disorder – Section 14.1.2

Maladaptive cognitions – Section 2.3.3.4

Managed health care – Section 1.4.7.3

Manic Episode – Section 4.2

Manifest content, of dreams – Section 2.3.1.4

Medulla – Section 2.2.1.6

Mental disorders – Section 1.1.3

Mental health, professionals – Section 1.6.1

Mental hygiene movement – Section 1.4.5

Mental status examination – Section 3.1.3.2

Mesmerism – Section 1.4.6.2

Middle Ages, and views of mental illness – Section 1.4.3

Mild Neurocognitive Disorder – Section 14.1.3

M’Naghten rule – Section 15.1.3

Model – Section 2.1.2

Modeling – Section 2.3.2.4

Mood disorders – Module 4

Symptoms of – Module 4.1

Types of – Module 4.1

Moral treatment movement – Section 1.4.5

Multicultural factors, and mental illness – Section 2.4.4

Multicultural psychology – Section 1.4.7.4

Multidimensional Models – Section 2.1.2

Multimethod study – Section 1.5.2.6

Myelin Sheath – Section 2.2.1.3

**N**

Narcissistic personality disorder – Section 13.1.3.4

Treatment of – Section 13.5.2.4

Negative symptoms – Section 12.1.16

Nerves – Section 2.2.1.3

Nervous system, parts of – Section 2.2.1.2

Communication in – Section 2.2.1.1

Neural Transmission – Section 2.2.1.4

Neurological tests – Section 3.1.3.4

Neurotransimtters – Section 2.2.1.4

Neuron – Section 2.2.1.3

NGRI – Section 15.1.3

Nomenclature – Section 1.2

Norepinephrine – Section 2.2.1.5

Norms (social) – Section 1.1.2

Nucleus – Section 2.2.1.3

**O**

Observational learning – Section 2.3.2.1; 2.3.2.4

OCD (Obsessive Compulsive Disorder) – Section 9.1.1

Epidemiology of – Section 9.2.1

Comorbidity of – Section 9.3.1

Treatment of – Section 9.5.1

Obsessive-compulsive personality disorder (OCPD) – Section 13.1.4.2

Operant conditioning – Section 2.3.2.3

Opioids – Section 11.1.2.3

Oral Stage – Section 2.3.1.2

**P**

Panic disorder – Section 7.1.5

Comorbidity – Section 7.3.5

Epidemiology of – Section 7.2.5

Treatment of – Section 7.5.5

Paranoid personality disorder – Section 13.1.2.1

Parkinson’s disease – Section 14.3.7

Parts of personality (id, ego, superego) – Section 2.3.1.1

Patient’s rights – Section 15.2

Pavlov, Ivan Petrovich – Section 2.3.2.2

Persecutory delusion – Section 12.1.5

Persistent Depressive Disorder – Section 4.1

Personality

Related to eating disorders – Section 10.5.4

Personality, development of – Section 2.3.1.2

Personality, structure of – Section 2.3.1.1

Personality disorders – Section 13.1.1

Personality inventories – Section 3.1.3.3

Psychological tests – Section 3.1.3.3

Phallic Stage – Section 2.3.1.2

Pharmacological – Section 14.4.1

Physical examination – Section 3.1.3.5

Polarized – Section 2.2.1.4

Pons – Section 2.2.1.6

Positive psychology – Section 1.1.1

Positive symptoms – Section 12.1.16

Positron Emission Tomography (PET) – Section 3.1.3.4

Prevention science – Section 1.4.7.6

Prescription rights for psychologists – Section 1.4.7.5

Presenting problem – Section 1.2

Prevalence – Section 1.2

Primary reinforcers/punishers – Section 2.3.2.3

Privileged communication – Section 15.3

Professional journals – Section 1.6.2.2

Professional societies – Section 1.6.2.1

Prognosis – Section 1.2

Projection – Section 2.3.1.3

Projective tests – Section 3.1.3.3

Psychiatric drugs – Section 1.4.7.2

Psychoanalysis – Section 2.3.1.4

Psychodynamic theory – Section 2.3.1

Evaluation of – Section 2.3.1.5

Related to dissociative disorders – Section 6.4.4

Related to somatic disorders – Section 8.4.1

Related to personality disorders – Section 13.4.2.1

Psychological or psychogenic perspective – Section 1.4.6.2

Psychological debriefing – Section 5.6.1

Psychomotor symptoms – Section 12.1.1.4

Psychopathology – Section 1.1.3

Psychopharmacology – Section 2.2.3.1

In relation to trauma and stressor related disorders – Section 5.6.5

In relation to somatic disorders – Section 8.5.2

In relation to schizophrenic disorders – Section 12.5.1

Psychophysiological Disorders – Section 8.6.1

Psychosis – Section 12.1.1

Psychosurgery – Section 2.2.3.3

Psychotherapy – Section 3.3.1.3

Related to somatic disorders – Section 8.5.1

Psychotropic drugs – Section 2.2.3.1

PTSD – Section 5.2.1

Epidemiology of – Section 5.3.1

Comorbidity of – Section 5.4.1

Punishment – Section 2.3.2.3

**Q**

**R**

Rape – Section 5.1

Rationalization – Section 2.3.1.3

Reaction formation – Section 2.3.1.3

Reactivity – Section 3.1.3.1

Receptor sites – Section 2.2.1.4

Reform movement, and views of mental illness – Section 1.4.5

Regression – Section 2.3.1.3

Reinforcement – Section 2.3.2.3

Reinforcement schedules – Section 2.3.2.3

Relative refractory period – Section 2.2.1.4

Reliability – Section 3.1.2

Renaissance, and views of mental illness – Section 1.4.4

Repolarized – Section 2.2.1.4

Repression – Section 2.3.1.3

Research Method – Section 1.5.2

Resistance – Section 2.3.1.4

Respondent conditioning – Section 2.3.2.2

Respondent discrimination – Section 2.3.2.2

Respondent extinction – Section 2.3.2.2

Respondent generalization – Section 2.3.2.2

Resting potential – Section 2.2.1.4

Reticular formation – Section 2.2.1.6

Reuptake – Section 2.2.1.4

Reversal design (ABAB design) – Section 1.5.2.5

Rogers, C. – Section 2.3.4.1

**S**

Schemas and cognitive errors – Section 2.3.3.2

Schizoaffective disorder – Section 12.1.4

Schizoid personality disorder – Section 13.1.2.2

Schizophrenia – Section 12.1.2

Schizophreniform disorder – Section 12.1.3

Schizotypal personality disorder – Section 13.1.2.3

Scientific method – Section 1.5.1

Secondary reinforcers/punishers – Section 2.3.2.3

Sedative-Hypnotic drugs – Section 11.1.2.2

Self-monitoring – Section 3.1.3.6

Self-serving bias – Section 2.3.3.3

Sensitization – Section 2.3.2.1

Serotonin – Section 2.2.1.5

Social anxiety disorder – Section 7.1.4

Comorbidity – Section 7.3.4

Epidemiology of – Section 7.2.4

Treatment of – Section 7.5.4

Social cognition – Section 1.3; 2.3.3.2

Social identity theory – Section 1.3

Sociocultural Model – Section 2.4

Evaluation of – Section 2.4.5

Related to mood disorders – Section 4.5.4

Related to trauma and stressor related disorders – Section 5.5.4

Related to dissociative disorders – Section 6.4.3

Related to anxiety disorders – Section 7.4.3

Related to somatic disorders – Section 8.4.4

Related to eating disorders – Section 10.5.3

Related to substance use and addictive disorders – Section 11.4.4; 11.5.4

Related to schizophrenic disorders – Section 12.4.3

Related to personality disorders – Section 13.4.3

Socioeconomic factors, and mental illness – Section 2.4.1

Soma – Section 2.2.1.3

Somatic delusion – Section 12.1.5

Somatic symptom and related disorders – Section 8.1

Somatic symptom disorder – Section 8.1.1

Specific Phobia – Section 7.1.1

Comorbidity – Section 7.3.2

Epidemiology of – Section 7.2.2

Treatment of – Section 7.5.2

Spontaneous recovery – Section 2.3.2.2

Stages of personality development – Section 2.3.1.2

Standardization – Section 3.1.2

Stigma – Section 1.3

Stimulants – Section 11.1.2.4

Epidemiology of – 11.2.2

Stressors – Section 5.1

Sublimation – Section 2.3.1.3

Substances – Section 11.1.1

Types of – Section 11.1.2

Substantia nigra – Section 2.2.1.6

Suicidality – Section 4.3.3

Synapse – Section 2.2.1.4

Synaptic gap/cleft/space – Section 2.2.1.4

Syndrome – Section 3.2.1

**T**

Target behavior – Section 3.1.3.6

Thalamus – Section 2.2.1.6

Thanatos – Section 2.3.1.1

Thematic Apperception Test – Section 3.1.3.3

Thorndike – Section 2.3.2.3

Transference – Section 2.3.1.4

Trauma-focused Cognitive behavioral therapy – Section 5.6.3

Threshold of excitation – Section 2.2.1.4

Tolerance – Section 11.1.1

Traumatic Brain Injury (TBI) – Section 14.3.2

Treatment – Section 1.2; Section 3.3.1

Related to mood disorders – Section 4.6

Related to trauma and stressor related disorders – Section 5.6

Related to dissociative disorders – Section 6.5

Related to anxiety disorders – Section 7.5

Related to somatic disorders – Section 8.5

Related to Psychological Factors Affecting Other Medical Conditions – Section 8.6.2

Related to obsessive compulsive disorders – Section 9.5

Related to eating disorders – Section 10.6

Related to substance-related and addictive disorders – Section 11.5

Related to schizophrenic disorders – Section 12.5

Related to personality disorders – Section 13.5

Related to neurocognitive disorders – Section 14.4

Trial and error learning – Section 2.3.2.3

Trephination – Section 1.4.1

**U**

Uni-Dimensional Model – Section 2.1.1

**V**

Validity – Section 3.1.2

Cross-sectional – Section 3.1.3.1

Vascular disorders – Section 14.3.3

Viral infections – Section 2.2.2.1

**W**

Watson, J.B. – Section 2.3.2.1

Withdrawal – Section 11.1.1

**X**

**Y**

**Z**